KRAS and colorectal carcinoma: Thus, our data show that heteronemin, tetrac, and their combination significantly decreased expressions of EGF and EGFR mRNA in both cell lines with different KRAS statuses, except for heteronemin alone in HCT-116 cells (KRAS MT CRC; Figure 7A–D).